Fund Holdings — Novo Holdings A/S

Total Portfolio Value:
$1.23B
Total Bought:
$69.85M
Total Sold:
$200.74M
Net Transaction:
-$130.89M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Edgewise Therapeutics, Inc.(EWTX)5,350,0005,350,0000$132.76M$168.53M13.65%+$35.76M
Brookfield CorporationCL A(BN)3,496,2453,496,2450$160.44M$141.49M11.46%-$18.95M
Asml Holding N VN Y REGISTRY SHS
N Y REGISTRY SHS
113,94694,946-19,000$121.91M$125.41M10.16%+$3.50M
Mirum Pharmaceuticals, Inc.(MIRM)1,264,0281,325,000+60,972$99.85M$122.40M9.92%+$22.56M
MapLight Therapeutics, Inc.(MPLT)3,686,6223,686,6220$64.76M$74.95M6.07%+$10.19M
Salesforce, Inc.(CRM)330,187393,187+63,000$87.47M$73.40M5.95%-$14.07M
Crinetics Pharmaceuticals In1,625,0001,550,000-75,000$75.64M$56.30M4.56%-$19.35M
Enliven Therapeutics Inc1,480,0001,280,000-200,000$22.79M$50.18M4.07%+$27.38M
Vaxcyte, Inc.(PCVX)916,160860,000-56,160$42.27M$49.97M4.05%+$7.70M
Pharvaris N V
COM
1,750,0001,750,0000$48.56M$49.44M4.01%+$875.0K
ArriVent BioPharma, Inc.(AVBP)1,942,1421,942,1420$39.08M$44.81M3.63%+$5.73M
Viridian Therapeutics, Inc.(VRDN)2,380,0002,000,000-380,000$74.07M$39.12M3.17%-$34.95M
Celldex Therapeutics, Inc.(CLDX)1,200,0001,200,0000$32.59M$38.06M3.08%+$5.47M
Apogee Therapeutics Inc570,000450,000-120,000$43.02M$37.88M3.07%-$5.15M
BioMarin Pharmaceutical Inc.(BMRN)660,000660,0000$39.22M$37.28M3.02%-$1.94M
4d Molecular Therapeutics In3,650,7373,650,7370$27.38M$33.99M2.75%+$6.61M
Alibaba Group Holding LimitedADS(BABA)257,327257,3270$37.72M$32.28M2.62%-$5.43M
Xenon Pharmaceuticals Inc.(XENE)0485,438+485,438$0$28.23M2.29%+$28.23M
BridgeBio Oncology Therapeutics, Inc.(BBOT)1,961,3172,185,923+224,606$24.56M$19.56M1.59%-$4.99M
Valneva SEADS(VALN)2,305,0001,057,421-1,247,579$20.33M$6.61M0.54%-$13.72M
LanzaTech Global, Inc.(LNZA)158,148158,1480$2.18M$2.53M0.21%+$355.8K
Marqeta, Inc.CL A(MQ)441,558441,5580$2.10M$1.80M0.15%-$295.8K
Insmed Incorporated(INSM)200,0000-200,000$34.81M$0—-$34.81M
Io Biotech Inc2,512,4530-2,512,453$1.53M$0—-$1.53M
Zenas BioPharma, Inc.(ZBIO)1,450,0000-1,450,000$52.65M$0—-$52.65M
Page 1 of 1
Novo Holdings A/S — 13F Holdings — Q1 2026 | TickerTrail